Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Zinc Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL4651551 | 0.82 | — | — | |
| Zinc Ion SCHEMBL30139847 | 0.82 | — | — | |
| Zinc Ion SCHEMBL30221145 | 0.82 | — | — | |
| Zinc Ion SCHEMBL4526923 | 0.82 | — | — | |
| Zinc Ion SCHEMBL6890873 | 0.82 | — | — | |
| Zinc Ion SCHEMBL7734062 | 0.82 | — | — | |
| Zinc Ion SCHEMBL10586475 | 0.82 | — | — | |
| Zinc Ion SCHEMBL384877 | 0.82 | — | — | |
| Zinc Ion SCHEMBL357899 | 0.82 | — | — | |
| Zinc Ion SCHEMBL11122846 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11554138-B2 | Bismuth(III) complexes as adjuvants in the treatment of cancer using platinum-based chemotherapy | THE UNIVERSITY OF HONG KONG (HK) | 2023-01-17 | — | — | US | disclosed |
| EP-3322413-B1 | BISMUTH (III) COMPLEXES AS ADJUVANTS IN THE TREATMENT OF CANCER USING CISPLATIN | UNIV HONG KONG (CN) | 2022-11-16 | — | — | EP | disclosed |